Candida albicans induces the release of inflammatory mediators from human peripheral blood monocytes

Inflammation

Volumn 20, Issue 1, 1996, Pages 107-122

  Castro, Mario ^a   Bjoraker, Julie A ^a   Rohrbach, Michael S ^a,b   Limper, Andrew H ^a,b  

^a Thoracic Diseases Research Unit   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BETA GLUCAN; CELL RECEPTOR; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MANNAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANDIDA ALBICANS; CELL SECRETION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE;

ARACHIDONIC ACID; CANDIDA ALBICANS; CELL WALL; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; GLUCANS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; LECTINS, C-TYPE; MANNANS; MANNOSE-BINDING LECTINS; MONOCYTES; OLIGOSACCHARIDES; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

CANDIDA ALBICANS; FUNGI;

EID: 0030044011     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01487749     Document Type: Article

References (48)

1. WEY, S. B., M. MORI, M. A. PFALLER, R. F. WOOLSON, and R. P. WENZEL. 1989. Risk factors for hospital acquired candidemia. Arch. Int. Med. 149:2349-2353.
2. EDWARDS, J. E. Candida species. 1990. In Principles and Practice of Infectious Diseases, 3rd Edn. G. L. Mandell, R. G. Douglas, J. E. Bennett, editors. Churchill Livingstone, New York. 1943-1958.
3. EDWARDS, J. E. 1987. Severe candidal infections. Clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann. Int. Med. 89:91-106.
4. EDWARDS, J. E. 1991. Invasive Candida infections. Evolution of a fungal pathogen. N. Engl. J. Med. 324:1060-1062.
5. MAKSYMIUK, A. W., S. THONGPRASERT, R. HOPPER, M. LUNA, V. FAINSTEIN, and G. P. BODEY. 1984. Systemic candidiasis in cancer patients. Am. J. Med. 77:20-27.
6. COCKAYNE, A., and F. C. ODDS. 1984. Interaction of Candida albicans yeast cells, germ tubes, and hyphae with human polymorphonuclear leukocytes in vitro. J. Gen. Microbiol. 130:465-471.
7. MARQUIS, G., S. GARZON, S. MONTPLAISIR, H. STRYKOWSKI, and N. BENHAMOU. 1991. Histochemical and immunochemical study of the fate of Candida albicans inside human neutrophil phagolysosomes. J. Leukoc. Biol. 50:587-599.
8. JANUSZ, M. J., K. F. AUSTEN, and J. K. CZOP. 1988. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte β-glucan receptors. Immunology 65:181-185.
9. MARODI, L., H. M. KORCHAK, and R. B. JOHNSTON. 1991. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 146:2783-2789.
10. SCHUIT, K. E. 1979. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect. Immun. 24:932-938.
11. FILLER, S. G., B. O. IBE, P. M. LUCKETT, J. U. RAJ, and J. E. EDWARDS. 1991. Candida albicans stimulates endothelial cell eicosanoid production. J. Infect. Dis. 164:928-935.
12. CASTRO, M., T. I. MORGENTHALER, N. V. C. RALSTON, M. S. ROHRBACH, and A. H. LIMPER. 1994. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through α-mannan and β-glucan cell wall components. Infect. Immun. 62:3138-3145.
13. KITZ, D. J., P. D. STAHL, and J. R. LITTLE. 1992. The effect of a mannose binding protein on macrophage interactions with Candida albicans. Cell. Mol. Biol. 38:407-12.
14. KANBE, T. H., M. A. JUTILA, and J. E. CUTLER. 1993. Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph nodes. Infect. Immun. 61:2578-2583.
15. EZEKOWITZ, R. A. B., D. J. WILLIAMS, H. KOZIEL, M. Y. K. ARMSTRONG, A. WARNER, F. F. RICHARDS, and R. M. ROSE. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351:155-158.
16. HOFFMAN, O. A., J. E. STANDING, and A. H. LIMPER. 1993. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan mediated mechanism. J. Immunol. 150:3932-3940.
17. NELSON, R. D., N. SHIBATA, R. P. PODZORSKI, and M. J. HERRON. 1991. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanism of action. Clin. Microbiol. Rev. 4:1-19.
18. SAN-BLAS, G. 1982. The cell wall of fungal human pathogens: Its possible role in host-parasite relationships. Mycopathologia 79:159-184.
19. PHAFF, H. J. 1963. Cell wall of yeasts. Annu. Rev. Microbiol. 17:15-30.
20. GOPAL, P., P. A. SULLIVAN, and M. G. SHEPHERD. 1984. Isolation and structure of glucan from regenerating spheroplasts of Candida albicans. J. Gen. Microbiol. 130:1217-1225.
21. DOMER, J. E., P. W. STASHAK, K. ELKINS, B. PRESCOTT, G. CALDES, and P. J. BAKER. 1986. Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components. Cell. Immunol. 101:403-414.
22. PODZORSKI, R. P., G. R. GRAY, and R. D. NELSON. 1990. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J. Immunol. 144:707-716.
23. HOSTAGER, B. S., M. J. HERRON, R. D. NAELSON, and B. H. GRAY. 1992. Candida albicans mannan glycoprotein: Role of the protein component in stimulation of cell-mediated immunity. FASEB J. 6:A2900.
24. PODZORSKI, R. P., and R. D. NELSON. 1989. Pathogenesis of candidiasis. Immunosuppression by cell wall mannan catabolites. Arch. Surg. 124:1290-1294.
25. DAUM, T., and M. S. ROHRBACH. 1993. Activation of alveolar macrophage arachidonic acid metabolism by particulate β-1,3-glucan. FEBS Lett. 309:119-122.
26. JANUSZ, M. J., K. F. AUSTEN, and J. K. CZOP. 1986. Isolation of soluble yeast β-glucans that inhibit human monocyte phagocytosis mediated by β-glucan receptors. J. Immunol. 137:3270-3276.
27. CZOP, J. K., and K. F. AUSTEN. 1985. A β-glucan-inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J. Immunol. 134:2588-2593.
28. CZOP, J. K., and K. F. AUSTEN. 1985. Generation of leukotrienes by human monocytes upon stimulation of their β-glucan receptor during phagocytosis. Proc. Natl. Acad. Sci. U.S.A. 82:2751-2755.
29. VUK-PAVLOVIC, Z., J. A. RUSSELL, and M. S. ROHRBACH. 1988. Cotton bract tannin: A novel human T-lymphocyte mitogen and a possible causative agent of byssinosis. Int. Arch. Allergy Appl. Immunol. 87:14-18.
30. KREOFSKY, T., J. W. SCHLAGER, Z. VUK-PAVLOVIC, R. T. ABRAHAM, and M. S. ROHRBACH. 1992. Condensed tannin promotes the release of arachidonic acid from rabbit resident alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 7:172-181.
31. HOFFMAN, O. A., E. J. OLSON, and A. H. LIMPER. 1993. Fungal β-glucan modulate macrophage release of tumor necrosis factor-α in response to bacterial lipopolysaccharide. Immunol. Lett. 37:19-25.
32. GOLDMAN, R. 1988. Characteristics of the β-glucan receptor of murine macrophages. Exp. Cell Res. 174:481-490.
33. SUNG, S. I., R. S. NELSON, and S. C. SILVERSTEIN. 1983. Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages. J. Cell Biol. 96: 160-166.
34. CZOP, J. K., N. M. VALIANTE, and M. J. JANUSZ. 1989. Phagocytosis of particulate activators of the human alternative complement pathway through monocyte beta-glucan receptors. Prog. Clin. Biol. Res. 297:287-96.
35. DAVIES, R. R., and T. J. V. DENNING. 1972. Candida albicans and the fungicidal activity of the blood. Sabouraudia 10:301-312.
36. LEHRER, R. I., and M. J. CLINE. 1969. Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol. 98:996-1004.
37. LEHRER, R. I. 1971. Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. II. Normal and chronic granulomatous disease eosinophils. Infect. Immun. 3:800-802.
38. LEHRER, R. I. 1975. The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J. Clin. Invest. 55:338-346.
39. 2 formation in macrophages interacting with certain bacteria. Eur. J. Biochem. 200:699-705.
40. WOLF, J. E., S. E. MASSOF, and S. P. PETERS. 1992. Alterations in murine macrophage arachidonic acid metabolism following ingestion of nonviable Histoplasma capsulatum. Infect. Immun. 60:2559-2564.
41. LOCKSLEY, R. M., J. FANKHAUSER, and W. R. HENDERSON. 1985. Alteration of leukotriene release by macrophages ingesting Toxoplasma gondii. Proc. Natl. Acad. Sci. U.S.A. 82:6922-6926.
42. REINER, N. E., and C. J. MALEMUD. 1985. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: In vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways. J. Immunol. 134:556-563.
43. 2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-γ. J. Immunol. 136:1820-1827.
44. DJEU, J. Y., D. K. BLANCHARD, A. L. RICHARDS, and H. FRIEDMAN. 1988. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J. Immunol. 141:4047-4052.
45. QIAN, Q., M. A. JUTILA, N. VAN ROOIJEN, and J. E. CUTLER. 1995. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
46. KELLEY, J. 1990. State of the Art: cytokines of the lung. Am. Rev. Respir. Dis. 141:765-788.
47. DINARELLO, C. A., and S. M. WOLFF. 1993. The role of interleukin-1 in disease. N. Engl. J. Med. 328:106-113.
48. SHALABY, M. R., B. B. AGGARWAL, E. RINDERKNECHT, L. P. SVEDERSKY, B. S. FINKLE, and M. A. PALLADINO. 1985. Activation of human polymorphonuclear neutrophil functions by interferon-α and tumor necrosis factor. J. Immunol. 135:2069-2074.